Back to search
Staphylococcus Aureus Pneumonia
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Staphylococcus Aureus Pneumonia trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Staphylococcus Aureus Pneumonia trials you may qualify forThe current IDSA/ATS guidelines recommend Linezolid and Vancomycin for MRSA coverage in hospitalized patients with pneumonia, which is common clinical practice…
This is an explorative, mono-center study including prospectively collected patient samples from the University Hospital of Basel. It is to investigate antimicr…
Severe community-acquired pneumonia (CAP) and community-acquired aspiration pneumonia (CAAP) are common reasons for adult emergency department visits and subseq…
This is a single-center, non-blinded, prospective, pilot study enrolling patients admitted to the critical care unit at Royal Columbian Hospital. This study inv…
Staphylococcus aureus expresses a variety of virulence factors, including Panton Valentine leukocidin (PVL), a cytotoxin. PVL is specifically associated with pr…